Showing 1 - 1 results of 1 for search 'Matteo Noto', query time: 0.03s
Refine Results
-
1
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study by Matteo Megna, Nello Tommasino, Luca Potestio, Teresa Battista, Angelo Ruggiero, Matteo Noto, Gabriella Fabbrocini, Lucia Genco
Published 2022-08-01
Article